BRIEF-Trevena reports positive top-line results from two phase 3 pivotal efficacy studies of intravenous oliceridine
February 21, 2017 at 07:26 AM EST
* Trevena announces positive top-line results from two phase 3 pivotal efficacy studies of intravenous oliceridine in moderate-to-severe acute pain
